1.59
price down icon1.24%   -0.02
after-market Dopo l'orario di chiusura: 1.57 -0.02 -1.26%
loading
Precedente Chiudi:
$1.61
Aprire:
$1.59
Volume 24 ore:
417.35K
Relative Volume:
0.14
Capitalizzazione di mercato:
$84.45M
Reddito:
-
Utile/perdita netta:
$-82.44M
Rapporto P/E:
-0.8457
EPS:
-1.88
Flusso di cassa netto:
$-66.75M
1 W Prestazione:
+10.42%
1M Prestazione:
-5.92%
6M Prestazione:
-46.64%
1 anno Prestazione:
-68.88%
Intervallo 1D:
Value
$1.55
$1.60
Intervallo di 1 settimana:
Value
$1.39
$1.64
Portata 52W:
Value
$1.195
$7.66

Black Diamond Therapeutics Inc Stock (BDTX) Company Profile

Name
Nome
Black Diamond Therapeutics Inc
Name
Telefono
617-417-5868
Name
Indirizzo
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Name
Dipendente
54
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
BDTX's Discussions on Twitter

Confronta BDTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
BDTX
Black Diamond Therapeutics Inc
1.59 84.45M 0 -82.44M -66.75M -1.88
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-31 Iniziato Raymond James Outperform
2023-07-14 Iniziato Piper Sandler Overweight
2023-06-30 Aggiornamento Stifel Hold → Buy
2023-06-28 Aggiornamento H.C. Wainwright Neutral → Buy
2023-06-27 Aggiornamento Wedbush Neutral → Outperform
2022-03-29 Downgrade Wedbush Outperform → Neutral
2022-03-22 Downgrade H.C. Wainwright Buy → Neutral
2021-09-30 Iniziato Stifel Hold
2021-01-07 Iniziato Wedbush Outperform
2020-11-24 Iniziato Berenberg Buy
2020-05-04 Iniziato H.C. Wainwright Buy
2020-02-24 Iniziato Canaccord Genuity Buy
2020-02-24 Iniziato Cowen Outperform
2020-02-24 Iniziato JP Morgan Overweight
2020-02-24 Iniziato Jefferies Buy
Mostra tutto

Black Diamond Therapeutics Inc Borsa (BDTX) Ultime notizie

pulisher
Apr 24, 2025

Black Diamond Therapeutics Inc (BDTX) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com

Apr 24, 2025
pulisher
Apr 19, 2025

Head-To-Head Contrast: Avalon GloboCare (NASDAQ:ALBT) and Black Diamond Therapeutics (NASDAQ:BDTX) - Defense World

Apr 19, 2025
pulisher
Apr 15, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Wellington Management Group LLP - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Raymond James Financial Inc. Purchases New Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Purchases Shares of 22,802 Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Apr 13, 2025
pulisher
Apr 04, 2025

Black Diamond stock hits 52-week low at $1.42 amid challenges - Investing.com India

Apr 04, 2025
pulisher
Apr 04, 2025

Black Diamond stock hits 52-week low at $1.42 amid challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 03, 2025

Black Diamond Therapeutics Inc [BDTX] stock for 11,997,749 USD was sold by BIOTECH GROWTH N V - knoxdaily.com

Apr 03, 2025
pulisher
Mar 31, 2025

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Mar 31, 2025
pulisher
Mar 29, 2025

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Stock Holdings Raised by Intech Investment Management LLC - The AM Reporter

Mar 29, 2025
pulisher
Mar 28, 2025

Bank of New York Mellon Corp Purchases 65,341 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Black Diamond Therapeutics’ Global Licensing Deal with Servier - Global Legal Chronicle

Mar 28, 2025
pulisher
Mar 26, 2025

BDTX stock touches 52-week low at $1.59 amid market challenges - Investing.com Australia

Mar 26, 2025
pulisher
Mar 25, 2025

Black Diamond Therapeutics Trades Well Below Cash After Lucrative Deal With Servier - Seeking Alpha

Mar 25, 2025
pulisher
Mar 24, 2025

What is Wedbush’s Estimate for BDTX Q1 Earnings? - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Sells 37,472 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

BB Biotech AG Reduces Stake in Black Diamond Therapeutics Inc - GuruFocus

Mar 22, 2025
pulisher
Mar 21, 2025

Black Diamond Therapeutic Stock Price, Quotes and Forecasts | NASDAQ:BDTX - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Stock Traders Buy High Volume of Call Options on Black Diamond Therapeutics (NASDAQ:BDTX) - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Growth Stocks To Add to Your Watchlist – March 19th - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Black Diamond Therapeutics (NASDAQ:BDTX) Earns “Outperform” Rating from Wedbush - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

HC Wainwright Has Bearish Forecast for BDTX Q1 Earnings - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Black Diamond Therapeutics sees $11.99m stock sale by BB Biotech AG - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Growth Stocks To Add to Your WatchlistMarch 19th - MarketBeat

Mar 20, 2025
pulisher
Mar 19, 2025

Black Diamond Therapeutics Surge: Savvy Move or Bubble? - timothysykes.com

Mar 19, 2025
pulisher
Mar 19, 2025

Black Diamond Gets The Gift Of Time In License Pact With Servier - insights.citeline.com

Mar 19, 2025
pulisher
Mar 19, 2025

Servier and Black Diamond enter oncology licensing deal By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, a Targeted Oncology Therapy - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Sector Update: Health Care -March 19, 2025 at 03:43 pm EDT - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Year-High - NewsBreak: Local News & Alerts

Mar 19, 2025
pulisher
Mar 19, 2025

This Biotech Is Finding Mid-Week Success Following Licensing Agreement Announcement - The Globe and Mail

Mar 19, 2025
pulisher
Mar 19, 2025

Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Yea - Asianet Newsable

Mar 19, 2025
pulisher
Mar 19, 2025

Black Diamond Therapeutics surges on licensing deal - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Black Diamond Therapeutics Inks Licensing Pact With French Pharma Firm Servier For Its Early-Stage Cancer Drug Worth Over $700 Million - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Black Diamond Therapeutics (BDTX) Stock Jumps After Entering Licensing Deal - Stocks Telegraph

Mar 19, 2025
pulisher
Mar 19, 2025

Black Diamond stock surges on licensing deal (BDTX:NASDAQ) - Seeking Alpha

Mar 19, 2025
pulisher
Mar 19, 2025

Servier and Black Diamond collaborate on BDTX-4933 - The Pharma Letter

Mar 19, 2025
pulisher
Mar 19, 2025

Black Diamond Therapeutics, Servier Sign Global Licensing Deal for BDTX-4933 to Treat Solid Tumors - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Servier and Black Diamond enter oncology licensing deal - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Black Diamond rises on licensing deal for tumor treatment - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Black Diamond stock soars on licensing deal By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Servier And Black Diamond Therapeutics Announce Global Licensing Agreement For BDTX-4933, A Targeted Oncology Therapy - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Servier and Black Diamond Therapeutics Announce Global - GlobeNewswire

Mar 19, 2025

Black Diamond Therapeutics Inc Azioni (BDTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Capitalizzazione:     |  Volume (24 ore):